The company’s generic business will come under a wholly owned subsidiary, Glenmark Generics, while innovative research initiatives and bran...

India Inc needs to invest in research and development to compete globally. But it will need to find ways to do so without losing too much m...

India Inc will need to find ways to invest in R&D without losing too much money and upsetting shareholders.

Once known for trashing patents and denouncing prohibitive pricing by big pharma, Indian generic companies have changed their stance.